~~<i id='CF7897BF14'><strike id='CF7897BF14'><tt id='CF7897BF14'><pre id='CF7897BF14'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

entertainment

author：focus 2025-08-23 04:58:14 - browse：924

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： CRISPR base editing slashes cholesterol levels in monkeys

leisure time

Wikipedia

leisure time

focus

hotspot

focus

AdobeWASHINGTON—AkeyObama-erainitiativewassupposedtosaveMedicaremoneybytestingnewpoliciesforcuttingh

WSS

UnitedHealth’s board chair also owns a personal investment firm

FDA warns J&J's Abiomed: We will regulate your software

FDA gives detailed accounting of AI

CEOs share strategies for surviving biotech slump

What will Novo Nordisk's VC do with its influx of cash?

The United States is paying nearly triple for new Covid vaccines

knowledge

entertainment

leisure time

In Memoriam: Notable people who died in 2023

Pharmacists can make shortage drugs, but at what cost?

Apple is now the first public company to be valued at $3 trillion

Senate committee scrutinizes Medicare Advantage brokers

Affirmative action in medical school literally saved lives

Hospital price transparency does save money, advocate argues

Virginia high school admissions case could be legal follow

CRISPR base editing slashes cholesterol levels in monkeys

The high cost of giving birth even with insurance

STAT Summit: Michael J. Fox on progress in Parkinson's research

Wikipedia

Setback for rare diseases as Taysha Gene Therapies pulls back

The stability of $0 premiums in Medicare Advantage

Medicare reduced heart disease by changing how it pays doctors

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Studies point to risks of excluding people with obesity from drug trials

Flu, Covid vaccination rates decline, new survey data show

leisure time

focus

hotspot

focus